Transgender Persons
20
5
6
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.0%
2 terminated out of 20 trials
81.8%
-4.7% vs benchmark
15%
3 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (20)
Effect of Testosterone Treatment on Drug Metabolism and Transport
MaPGAS Decision Making
Research Participation With Transgender and Gender-Diverse Youth
Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons
Effect of Estrogen Treatment on Drug Metabolism and Transport
Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France
Trans & Non-binary Reference Intervals While on Hormone Therapy Study
Perception of Pain During Gender Affirming Hormone Therapy
TransHealthGUIDE: Transforming Health for Gender-Diverse Young Adults
The Experiences of Erotic and Sexual Risk of Transgender Men: Exploratory Research Design
Effect of Gender Affirming Hormone Therapy on Glucose Metabolism
Investigation of the Perceptual and Acoustic Voice in Trans Man
Transgender Estradiol
Cohort Study on Factors Associated with the Evolution of Quality of Life Among Transgender Individuals in the French Population
New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen
Transgender Observational Performance
The Impact of COVID-19 Outbreak on Trans-population's Health in Italy
The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community